India Oncology Market (2026-2032) | Share, Analysis, Companies, Value, Trends, Competitive Landscape, Outlook, Growth, Segmentation, Industry, Forecast, Size & Revenue

Market Forecast By Cancer Type (Lung cancer, Prostate cancer, Colon & rectal cancer, Gastric cancer, Others), By End-use (Hospitals, Diagnostic laboratories, Diagnostic imaging centers, Academia, Specialty clinics, Others) And Competitive Landscape

Product Code: ETC7549476 Publication Date: Sep 2024 Updated Date: Dec 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Dhaval Chaurasia No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

India Oncology Market Growth Rate

According to 6Wresearch internal database and industry insights, the India Oncology Market is projected to grow at a compound annual growth rate (CAGR) of 7.8% during the forecast period (2026-2032).

Five-Year Growth Trajectory of the India Oncology Market with Core Drivers

Below mentioned are the evaluation of years-wise growth rate along with key growth drivers:

Year CAGR (%) Growth Drivers
2021 4.3 Expansion of tertiary care cancer hospitals and increased diagnostic reach
2022 5.1 Growing adoption of advanced imaging and pathology services
2023 5.9 Rising prevalence of lifestyle-related cancers and early screening
2024 6.6 Government investment in oncology infrastructure and AI-based diagnostics
2025 7.2 Increasing availability of targeted therapies and precision oncology

Topics Covered in the India Oncology Market Report

The India Oncology Market report thoroughly covers the market by cancer type and end-use. The market report provides an unbiased and detailed analysis of ongoing market trends, opportunities/high growth areas, and market drivers, which help stakeholders devise and align their market strategies according to the current and future market dynamics.

India Oncology Market Highlights

Report Name India Oncology Market
Forecast period 2026-2032
CAGR 7.8%
Growing Sector Hospitals & Specialty Oncology Clinics

India Oncology Market Synopsis

India Oncology Market is anticipated to record strong growth due to the rising burden of cancer, expanding diagnostic coverage, and rapid adoption of advanced treatment modalities. Apart from this, growing urbanization, change in lifestyle patterns, and increasing geriatric population have led to higher incidence of lung, colorectal, and prostate cancers. Besides, strong government focus on strengthening cancer care under national health missions, along with increasing private sector investments in oncology hospitals and diagnostic imaging centers, is significantly improving treatment accessibility across the country.

Evaluation of Growth Drivers in the India Oncology Market

Below mentioned are some prominent drivers and their influence to the market dynamics:

Drivers Primary Segments Affected Why it Matters (Evidence)
Rising Cancer Incidence All Cancer Types; Hospitals Higher disease prevalence directly increases diagnostic and treatment demand.
Expansion of Advanced Diagnostics Diagnostic Imaging; Laboratories Early and accurate detection improves treatment outcomes and therapy adoption.
Growth of Precision Oncology Medication; Hospitals Use of targeted and immuno-oncology therapies increases treatment effectiveness.
Private Hospital Investments Hospitals; Specialty Clinics Corporate hospital chains expand oncology capacity across emerging centres.
Government Focus on Cancer Care All Types; Hospitals & Academia Public programs augments affordability and access to oncology services.

India Oncology Market is expected to grow at the CAGR of 7.8% during the forecast period of 2026-2032. Growth is driven by increasing cancer burden, improving diagnostic infrastructure, wider availability of targeted therapies, and continuous government initiatives aimed at strengthening oncology care delivery nationwide. In addition, rising awareness about early cancer screening, expanding insurance coverage for oncology treatments, and increasing private sector participation in specialty cancer hospitals are further supporting India Oncology Market Growth.

Evaluation of Restraints in the India Oncology Market

Below mentioned are some major restraints and their influence to the market dynamics:

Restraints Primary Segments Affected What This Means (Evidence)
Infrastructure Gaps Diagnostic Imaging; Clinics Inadequate availability of PET-CT and radiotherapy units in smaller cities.
High Cost of Advanced Therapies Medication; Specialty Clinics Targeted and immunotherapies remain unaffordable for many patients.
Lack of Skilled Oncologists All Types; Hospitals Demand-supply gap affects quality and speed of treatment.
Delayed Diagnosis Diagnostic Services; Others Late-stage detection upsurges treatment complexity and costs.
Infrastructure Gaps Diagnostic Imaging; Clinics Inadequate availability of PET-CT and radiotherapy units in smaller cities.

India Oncology Industry Challenges

There are various challenges deterring the growth of India Oncology Industry. Key barriers are high treatment costs, inadequate specialized oncology professionals, and regional disparities in healthcare access. In addition to this, delayed diagnosis, limited insurance penetration for advanced cancer therapies, and infrastructure gaps in rural areas continue to restrict optimal treatment outcomes.

India Oncology Market Trends

The oncology industry of India is experiencing various influential trends such as:

  • AI-Based Cancer Diagnostics: This emerging trend suggests integration of artificial intelligence in imaging and pathology as it enhances accuracy and early detection.
  • Wide Adoption of Immuno-Oncology Treatments: There has been upsurging use of immunotherapies which further improves survival rates and expanding treatment options.
  • Day-Care Chemotherapy Models: The introduction of this model lowers treatment costs and hospital burden due to wide adoption of such models by hospitals.

Investment Opportunities in the India Oncology Market

There are various prominent investment opportunities available in the India Oncology Market which includes:

  • Comprehensive Cancer Hospital Development – Expansion of multi-specialty oncology centers in Tier II and Tier III cities.
  • Unconventional Diagnostic Imaging Centers – This opportunity signifies establishment of PET-CT, molecular pathology, and genomic testing labs.
  • Affordable Oncology Drug Manufacturing – This opportunity implies local production of biosimilars and targeted therapies to reduce treatment costs.

Top 5 Leading Players in the India Oncology Market

Some leading players operating in the India Oncology Market include:

1. Sun Pharmaceutical Industries Ltd.

Company Name Sun Pharmaceutical Industries Ltd.
Established Year 1983
Headquarters Mumbai, India
Official Website Click Here

Sun Pharma provides a wide and diversified portfolio of oncology drugs, including targeted therapies, hormonal treatments, and specialty medicines, and plays a significant role in improving treatment accessibility.

2. Dr. Reddy’s Laboratories Ltd.

Company Name Dr. Reddy’s Laboratories Ltd.
Established Year 1984
Headquarters Hyderabad, India
Official Website Click Here

Dr. Reddy’s focuses on the development and supply of affordable oncology medicines and biosimilars, supporting wider patient access to advanced cancer therapies.

3. Cipla Ltd.

Company Name Cipla Ltd.
Established Year 1935
Headquarters Mumbai, India
Official Website Click Here

Cipla offers a broad range of chemotherapy agents and supportive oncology drugs, and is actively involved in improving treatment affordability, enhancing patient adherence, and expanding access to essential cancer medicines across tertiary hospitals and regional cancer centers.

4. Roche India Pvt. Ltd.

Company Name Roche India Pvt. Ltd.
Established Year 1967
Headquarters Mumbai, India
Official Website Click Here

Roche India supplies advanced oncology medicines, precision therapies, and diagnostic solutions, supporting the adoption of personalized cancer treatment approaches.

5. Tata Memorial Centre

Company Name Tata Memorial Centre
Established Year 1941
Headquarters Mumbai, India
Official Website Click Here

Tata Memorial Centre is a leading cancer research, education, and treatment institution in India, playing a critical role in clinical research, oncology training, and early detection programs.

Government Regulations Introduced in the India Oncology Market

According to Indian Government Data, several initiatives have been introduced to strengthen oncology care and boost the India Oncology Market Growth. For example, the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) emphasize on early screening and cancer management. Furthermore, Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (PM-JAY) provides financial coverage for cancer treatment, while state governments have launched free cancer screening and radiotherapy programs in public hospitals to improve access and affordability.

Future Insights of the India Oncology Market

In the future years, the outlook for the India Oncology Market will remain strong and increasingly resilient, backed by surging investments in precision medicine, unceasing development of advanced diagnostic imaging infrastructure, and wider integration of digital oncology platforms across hospitals and specialty clinics. In addition, sustained government focus on early detection programs, affordable treatment delivery models, capacity building for oncology professionals, and improved insurance coverage is expected to enhance patient access, treatment outcomes, and long-term market growth across both urban and emerging regional healthcare ecosystems.

Market Segmentation Analysis

The report offers a comprehensive study of the subsequent market segments and their leading categories.

Lung Cancer to Dominate the Market – By Cancer Type

According to Mohit, Senior Research Analyst, 6Wresearch, lung cancer dominates the India Oncology Market due to high prevalence linked to smoking, air pollution, and occupational exposure. Rising use of targeted therapies and immunotherapy has further increased treatment adoption for lung cancer patients.

Hospitals to Dominate the Market – By End-use

Hospitals are expected to lead the India Oncology Market share owing to advanced diagnostic facilities, availability of multidisciplinary oncology teams, and comprehensive treatment services including chemotherapy, radiotherapy, and surgery.

Key Attractiveness of the Report

  • 10 Years of Market Numbers.
  • Historical Data Starting from 2022 to 2025.
  • Base Year: 2025.
  • Forecast Data until 2032.
  • Key Performance Indicators Impacting the Market.
  • Major Upcoming Developments and Projects.

Key Highlights of the Report:

  • India Oncology Market Outlook
  • Market Size of India Oncology Market, 2025
  • Forecast of India Oncology Market, 2032
  • Historical Data and Forecast of India Oncology Revenues & Volume for the Period 2022- 2032
  • India Oncology Market Trend Evolution
  • India Oncology Market Drivers and Challenges
  • India Oncology Price Trends
  • India Oncology Porter's Five Forces
  • India Oncology Industry Life Cycle
  • Historical Data and Forecast of India Oncology Market Revenues & Volume By Cancer Type for the Period 2022- 2032
  • Historical Data and Forecast of India Oncology Market Revenues & Volume By Lung cancer for the Period 2022- 2032
  • Historical Data and Forecast of India Oncology Market Revenues & Volume By Prostate cancer for the Period 2022- 2032
  • Historical Data and Forecast of India Oncology Market Revenues & Volume By Colon & rectal cancer for the Period 2022- 2032
  • Historical Data and Forecast of India Oncology Market Revenues & Volume By Gastric cancer for the Period 2022- 2032
  • Historical Data and Forecast of India Oncology Market Revenues & Volume By Others for the Period 2022- 2032
  • Historical Data and Forecast of India Oncology Market Revenues & Volume By End-use for the Period 2022- 2032
  • Historical Data and Forecast of India Oncology Market Revenues & Volume By Hospitals for the Period 2022- 2032
  • Historical Data and Forecast of India Oncology Market Revenues & Volume By Diagnostic laboratories for the Period 2022- 2032
  • Historical Data and Forecast of India Oncology Market Revenues & Volume By Diagnostic imaging centers for the Period 2022- 2032
  • Historical Data and Forecast of India Oncology Market Revenues & Volume By Academia for the Period 2022- 2032
  • Historical Data and Forecast of India Oncology Market Revenues & Volume By Specialty clinics for the Period 2022- 2032
  • Historical Data and Forecast of India Oncology Market Revenues & Volume By Others for the Period 2022- 2032
  • India Oncology Import Export Trade Statistics
  • Market Opportunity Assessment By Cancer Type
  • Market Opportunity Assessment By End-use
  • India Oncology Top Companies Market Share
  • India Oncology Competitive Benchmarking By Technical and Operational Parameters
  • India Oncology Company Profiles
  • India Oncology Key Strategic Recommendations

Market Covered

The report offers a comprehensive study of the subsequent market segments:

By Cancer Type

  • Lung cancer
  • Prostate cancer
  • Colon & rectal cancer
  • Gastric cancer
  • Others

By End-use

  • Hospitals
  • Diagnostic laboratories
  • Diagnostic imaging centers
  • Academia
  • Specialty clinics
  • Others

India Oncology Market (2026-2032) : FAQ's

India Oncology Market is projected to grow at a CAGR of 7.8% between 2026-2032.
Lung cancer contributes the highest share due to rising incidence and advanced treatment adoption.
Increasing prevalence of varied type of cancers, increasing geriatric population, and rising adoption of advanced therapies are the major aspects driving growth in the India Oncology Market.
The growth of India Oncology Market is hampering due to high treatment costs and uneven access to advanced oncology services.
6Wresearch actively monitors the India Oncology Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the India Oncology Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
1 Executive Summary
2 Introduction
2.1 Key Highlights of the Report
2.2 Report Description
2.3 Market Scope & Segmentation
2.4 Research Methodology
2.5 Assumptions
3 India Oncology Market Overview
3.1 India Country Macro Economic Indicators
3.2 India Oncology Market Revenues & Volume, 2022 & 2031F
3.3 India Oncology Market - Industry Life Cycle
3.4 India Oncology Market - Porter's Five Forces
3.5 India Oncology Market Revenues & Volume Share, By Cancer Type, 2022 & 2031F
3.6 India Oncology Market Revenues & Volume Share, By End-use, 2022 & 2031F
4 India Oncology Market Dynamics
4.1 Impact Analysis
4.2 Market Drivers
4.2.1 Increasing prevalence of cancer in India
4.2.2 Technological advancements in oncology treatments
4.2.3 Growing healthcare infrastructure and facilities
4.2.4 Rise in disposable income leading to higher healthcare spending
4.3 Market Restraints
4.3.1 High treatment costs and lack of insurance coverage
4.3.2 Limited access to specialized oncology care in rural areas
4.3.3 Stringent regulatory requirements for new cancer therapies
4.3.4 Shortage of skilled oncology professionals
5 India Oncology Market Trends
6 India Oncology Market, By Types
6.1 India Oncology Market, By Cancer Type
6.1.1 Overview and Analysis
6.1.2 India Oncology Market Revenues & Volume, By Cancer Type, 2022- 2031F
6.1.3 India Oncology Market Revenues & Volume, By Lung cancer, 2022- 2031F
6.1.4 India Oncology Market Revenues & Volume, By Prostate cancer, 2022- 2031F
6.1.5 India Oncology Market Revenues & Volume, By Colon & rectal cancer, 2022- 2031F
6.1.6 India Oncology Market Revenues & Volume, By Gastric cancer, 2022- 2031F
6.1.7 India Oncology Market Revenues & Volume, By Others, 2022- 2031F
6.2 India Oncology Market, By End-use
6.2.1 Overview and Analysis
6.2.2 India Oncology Market Revenues & Volume, By Hospitals, 2022- 2031F
6.2.3 India Oncology Market Revenues & Volume, By Diagnostic laboratories, 2022- 2031F
6.2.4 India Oncology Market Revenues & Volume, By Diagnostic imaging centers, 2022- 2031F
6.2.5 India Oncology Market Revenues & Volume, By Academia, 2022- 2031F
6.2.6 India Oncology Market Revenues & Volume, By Specialty clinics, 2022- 2031F
6.2.7 India Oncology Market Revenues & Volume, By Others, 2022- 2031F
7 India Oncology Market Import-Export Trade Statistics
7.1 India Oncology Market Export to Major Countries
7.2 India Oncology Market Imports from Major Countries
8 India Oncology Market Key Performance Indicators
8.1 Number of oncology clinical trials conducted in India
8.2 Adoption rate of advanced oncology treatments
8.3 Percentage of cancer patients receiving timely diagnosis and treatment
8.4 Investment in oncology research and development
8.5 Patient satisfaction with oncology care services
9 India Oncology Market - Opportunity Assessment
9.1 India Oncology Market Opportunity Assessment, By Cancer Type, 2022 & 2031F
9.2 India Oncology Market Opportunity Assessment, By End-use, 2022 & 2031F
10 India Oncology Market - Competitive Landscape
10.1 India Oncology Market Revenue Share, By Companies, 2022-2032F
10.2 India Oncology Market Competitive Benchmarking, By Operating and Technical Parameters
11 Company Profiles
12 Recommendations
13 Disclaimer

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All
Chat With 6W AI Intelligence